Sotera Health (NASDAQ:SHC) Director Sells $193,194,516.17 in Stock

Sotera Health Company (NASDAQ:SHC) Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Gtcr Investment Xi Llc also recently made the following trade(s):

• On Friday, March 6th, Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00.

Sotera Health Price Performance

Sotera Health stock opened at $15.27 on Monday. Sotera Health Company has a one year low of $10.80 and a one year high of $19.85. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. The business has a fifty day moving average of $14.88 and a two-hundred day moving average of $16.43. The company has a market cap of $4.35 billion, a P/E ratio of 37.24 and a beta of 1.82.

Sotera Health (NASDAQ:SHC) last released its earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. During the same quarter last year, the company earned $0.14 earnings per share. Sotera Health’s quarterly revenue was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, analysts predict that Sotera Health Company will post 0.86 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on SHC. Zacks Research cut Sotera Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 30th. Piper Sandler restated an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a research report on Wednesday, May 6th. Wall Street Zen cut Sotera Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, April 11th. Barclays dropped their price target on Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Finally, Citigroup raised their price target on Sotera Health from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. Seven analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $20.33.

Institutional Trading of Sotera Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. The Manufacturers Life Insurance Company increased its position in Sotera Health by 11.3% during the 1st quarter. The Manufacturers Life Insurance Company now owns 166,955 shares of the company’s stock worth $2,394,000 after purchasing an additional 16,990 shares in the last quarter. Lazard Asset Management LLC increased its position in Sotera Health by 313.0% during the 1st quarter. Lazard Asset Management LLC now owns 182,931 shares of the company’s stock worth $2,623,000 after purchasing an additional 138,636 shares in the last quarter. ABS Direct Equity Fund LLC purchased a new stake in Sotera Health during the 1st quarter worth about $717,000. Sculptor Capital LP increased its position in Sotera Health by 3.4% during the 1st quarter. Sculptor Capital LP now owns 21,717,728 shares of the company’s stock worth $311,432,000 after purchasing an additional 717,728 shares in the last quarter. Finally, Rangeley Capital LLC purchased a new stake in Sotera Health during the 1st quarter worth about $143,000. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.